首页> 外文期刊>Biomarkers in medicine >Standardization efforts enabling next-generation sequencing and microarray based biomarkers for precision medicine
【24h】

Standardization efforts enabling next-generation sequencing and microarray based biomarkers for precision medicine

机译:标准化工作使下一代测序和基于微阵列的生物标记物可用于精密医学

获取原文
获取原文并翻译 | 示例
       

摘要

Microarrays and next-generation sequencing technologies have been increasingly employed in biomedical research. However, before they can be reliably used as clinical biomarker tests, standardization and quality control measures need to be developed to ensure their analytical validity. This review summarizes community-wide efforts such as the MicroArray and Sequencing Quality Control (MAQC/SEQC) project which have identified factors influencing the performance of these technologies. Consequently, consensus-based standards and well-documented best practices have been developed to improve the quality of scientific research, and reference materials and reference datasets have been made available for evaluating the technical proficiency in future studies. These efforts have built the foundation on which the translational application of genomics based technologies can help realize precision medicine.
机译:微阵列和下一代测序技术已越来越多地应用于生物医学研究中。但是,在将其可靠地用作临床生物标志物测试之前,需要制定标准化和质量控制措施以确保其分析有效性。这篇综述总结了整个社区的努力,例如微阵列和测序质量控制(MAQC / SEQC)项目,这些项目已经确定了影响这些技术性能的因素。因此,已经开发了基于共识的标准和有据可查的最佳实践,以提高科学研究的质量,并且提供了参考资料和参考数据集以评估未来研究中的技术水平。这些努力为基于基因组学的技术的翻译应用可以帮助实现精确医学奠定了基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号